The current work investigated the synthesis possibility of oxidized gum arabic cross-linked pectin/O-carboxymethyl chitosan hydrogels (OGA-Pc-O-CMCS) as a pH-sensitive adsorbent vehicle. During the hydrogel fabrication, the cross-linker oxidized gum arabic (OGA) plays an important role in the enhancement of mechanical stability and the structural compactness of the hydrogel. The effect of OGA content, reaction time, reaction temperature, and reaction pH on the hydrogel swelling and crosslink degree was evaluated, modeled, and optimized statistically using response surface methodology (RSM) based on central composite design (CCD). As the pH of pectin/O-Carboxymethyl chitosan (Pc-O-CMCS) complexation increased up to 6.0, the swelling degree of the hydrogels decreased regardless of the concentration of the OGA. The swelling indices of 101.35% and 70.552% showed the optimum RSM results in the acidic and neutral medium, respectively. The adsorption efficiency of two conventional fluoroquinolones antibiotics (Levofloxacin (LVX) and Delafloxacin (DLX)) in the optimized hydrogel formulations was investigated. The obtained results confirmed that OGA concentration was an important parameter in the swelling processes. The adsorption capacity of the hydrogels was higher in acidic medium (pH 3.9) compared to natural medium (pH 7.1), which indicates the pH-sensitive adsorption behavior of the prepared hydrogel. The maximum antibiotic adsorption occurred after 12 hours: (66.3`-87.5%) and (45`-53%) for pH 3.9 and 7.1, respectively. The shape and morphological analysis of the beads before and after adsorption was performed using field emission scanning electron microscopy (FE-SEM). The FE-SEM analysis revealed that the shape of the beads changed significantly because of erosion and swelling activity after antibiotics adsorption. Experimental results exhibited that SIP model fitted best to the isotherm adsorption of LVX and DLX onto OGA-Pc-O-CMCS hydrogel.
机构:
Wenzhou Med Coll, Inst Biomed Engn, Sch Ophthalmol & Optometry, Wenzhou 325027, Peoples R China
Wenzhou Med Coll, Hosp Eye, Wenzhou 325027, Peoples R ChinaWenzhou Med Coll, Inst Biomed Engn, Sch Ophthalmol & Optometry, Wenzhou 325027, Peoples R China
Li, Xingyi
Kong, Xiangye
论文数: 0引用数: 0
h-index: 0
机构:
Sichuan Univ, State Key Lab Biotherapy, W China Med Sch, W China Hosp, Chengdu 610041, Peoples R China
Sichuan Univ, Ctr Canc, W China Med Sch, W China Hosp, Chengdu 610041, Peoples R ChinaWenzhou Med Coll, Inst Biomed Engn, Sch Ophthalmol & Optometry, Wenzhou 325027, Peoples R China
Kong, Xiangye
Zhang, Zhaoliang
论文数: 0引用数: 0
h-index: 0
机构:
Wenzhou Med Coll, Inst Biomed Engn, Sch Ophthalmol & Optometry, Wenzhou 325027, Peoples R China
Wenzhou Med Coll, Hosp Eye, Wenzhou 325027, Peoples R ChinaWenzhou Med Coll, Inst Biomed Engn, Sch Ophthalmol & Optometry, Wenzhou 325027, Peoples R China
Zhang, Zhaoliang
Nan, Kaihui
论文数: 0引用数: 0
h-index: 0
机构:
Wenzhou Med Coll, Inst Biomed Engn, Sch Ophthalmol & Optometry, Wenzhou 325027, Peoples R China
Wenzhou Med Coll, Hosp Eye, Wenzhou 325027, Peoples R ChinaWenzhou Med Coll, Inst Biomed Engn, Sch Ophthalmol & Optometry, Wenzhou 325027, Peoples R China
Nan, Kaihui
Li, LingLi
论文数: 0引用数: 0
h-index: 0
机构:
Wenzhou Med Coll, Inst Biomed Engn, Sch Ophthalmol & Optometry, Wenzhou 325027, Peoples R China
Wenzhou Med Coll, Hosp Eye, Wenzhou 325027, Peoples R ChinaWenzhou Med Coll, Inst Biomed Engn, Sch Ophthalmol & Optometry, Wenzhou 325027, Peoples R China
Li, LingLi
Wang, XianHou
论文数: 0引用数: 0
h-index: 0
机构:
Tianjin Med Univ, Dept Lymphoma, Sino US Ctr Lymphoma & Leukemia, Canc Hosp & Inst,Key Lab Canc Prevent & Therapy, Tianjin 300060, Peoples R ChinaWenzhou Med Coll, Inst Biomed Engn, Sch Ophthalmol & Optometry, Wenzhou 325027, Peoples R China
Wang, XianHou
Chen, Hao
论文数: 0引用数: 0
h-index: 0
机构:
Wenzhou Med Coll, Inst Biomed Engn, Sch Ophthalmol & Optometry, Wenzhou 325027, Peoples R China
Wenzhou Med Coll, Hosp Eye, Wenzhou 325027, Peoples R ChinaWenzhou Med Coll, Inst Biomed Engn, Sch Ophthalmol & Optometry, Wenzhou 325027, Peoples R China